Compounds > bicalutamide

bicalutamide and Polycystic Ovary Syndrome

bicalutamide has been researched along with Polycystic Ovary Syndrome in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
De Leo, V; Di Giacinto, P; Exacoustos, C; Guccione, L; Lenzi, A; Moretti, C; Motta, C; Petraglia, F; Simonelli, I; Toscano, V1
Aslan, C; Bahceci, M; Canoruc, N; Kidir, V; Tuzcu, A; Tuzun, Y1

Trials

2 trial(s) available for bicalutamide and Polycystic Ovary Syndrome

ArticleYear
Combined Oral Contraception and Bicalutamide in Polycystic Ovary Syndrome and Severe Hirsutism: A Double-Blind Randomized Controlled Trial.
    The Journal of clinical endocrinology and metabolism, 2018, 03-01, Volume: 103, Issue:3

    Topics: Adult; Androgen Antagonists; Anilides; Anthropometry; Body Composition; Contraceptives, Oral, Combined; Dermoscopy; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Hirsutism; Humans; Nitriles; Polycystic Ovary Syndrome; Tosyl Compounds; Treatment Outcome; Ultrasonography; Video Recording

2018
Serum C-reactive protein (CRP) levels and insulin resistance in non-obese women with polycystic ovarian syndrome, and effect of bicalutamide on hirsutism, CRP levels and insulin resistance.
    Hormone research, 2004, Volume: 62, Issue:6

    Topics: Adult; Androgen Antagonists; Anilides; Anthropometry; Blood Glucose; C-Reactive Protein; Female; Hirsutism; Hormones; Humans; Insulin Resistance; Lipids; Nitriles; Polycystic Ovary Syndrome; Tosyl Compounds

2004